By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Capsalus today said it has signed a letter of intent to buy the marketing rights and assets of GeneWize Life Sciences for an undisclosed amount.

GeneWize is the wholly-owned direct-selling subsidiary of consumer genomics firm GeneLink Biosciences and provides DNA customized nutritional supplements, skin care, and gene modulating weight management products.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.